Abstract Membrane proteins are primary targets for most therapeutic indications in cancer and neurological diseases. binding over 50% of all known small molecule drugs. Understanding how such ligands impact membrane proteins requires knowledge on the molecular structure of ligand binding. a reasoning that has driven relentless efforts in drug discovery and translational research. https://www.ivoryjinelle.com/